Ironwood Pharmaceuticals is an American pharmaceuticals giant which leads in developing and manufacturing of generic drugs and market medicines of eclectic combinations. The company is headquartered in Cambridge, Massachusetts and is listed on NASDAQ stock exchange with the symbol IRWD. Most of the products manufactured are used in the treatment of problems related to cardiovascular diseases, cholesterol, gastrointestinal, pain, inflammation and various others.
The company as of now has many production facilities along with Research and Development labs which are based in the United States. Currently, Peter Hecht serves the corporation as CEO, Brian Cali as the Senior Vice President of preclinical R&D while Todd Milne functions as its Vice President of sGC R&D.